|
|
|
Current understanding of how the body functions and how diseases develop owes much to the sequencing of the human genome. The new research concepts and technological innovations that have followed help the study and understanding of the molecular mechanisms of illness. Despite the progress made, we are still far from developing effective and selective therapeutics for many threatening diseases.
Axxam is a leader in gene expression profiling for drug target discovery and our mission is to help accelerate drug target discovery and development that leads to new therapeutic compounds. Since 2004, Axxam Gene Expression has been applying innovative research approaches to identify and select promising targets for new therapeutic mechanisms. Such targets are identified by gene expression studies mainly on cells and tissues of human origin and on tissues from animal models.
We concentrate our efforts on three therapeutic areas with significant unmet medical needs:
For partnering opportunities of selected targets in any of these therapeutic areas, please contact us. |
|
|
|
|
|
|
